Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL)

Figures & data

Figure 1 ADL and functional vision questionnaire. Evaluations take place prior to and after surgery with IOL implantation (Image courtesy Borkenstein & Borkenstein, Praxis für operative und konservative Augenheilkunde).

Table 1 Summary of Available IOLs and Published Data

IOL	Binocularity/Magnification	Efficacy	Safety
Implantable Miniature Telescope (IMT)	Monocular, 2.7x^Citation4,Citation15,Citation27,Citation32	Mean BCDVA improvement of 2.41 (± 2.69) lines (76/217 patients evaluable at week 60)^Citation27	Iritis >30 days after surgery (10.0%), patients 65 to <75^Citation27 Decrease >2 lines BCDVA (7.9%) and telescope removal (7.9%), patients ≥75^Citation27
Intra ocular lens for visually impaired people (IOL-VIP)	Binocular, 1.3x^Citation4,Citation15,Citation17	All 40 eyes (35 patients) improved BCVA (mean pre-and post-operative logMAR BCVA: 1.47 vs 0.87, respectively, for patients with “very poor” VA; 0.85 vs 0.50, respectively, for patients with “relatively good” VA)^Citation17	“No cases of intraoperative or postoperative complications were detected”^Citation17
EyeMax Mono	Binocular, 1.2x^Citation18,Citation22^–^Citation24	Mean CDVA logMAR improvement (244 patient case-series): −0.35 (95% CI, −0.39 to −0.32, P<0.0001; ETDRS equivalent of 18 letters gain).^Citation21	Frequency of perioperative complications equivalent to standard IOL implantation^Citation18
Scharioth Macula Lens	Monocular, 2–3x (dependent on reading distance)^Citation4,Citation15,Citation22^–^Citation24	Preoperative corrected VA correlated with postoperative uncorrected VA (in a prospective clinical trial at 12 months, 50 eyes)^Citation24	No intraoperative complications; no change in mean intraocular pressure; no change in foveal thickness by OCT^Citation24
Fresnel Prism Intraocular Lens	Monocular, no magnification^Citation4,Citation25	Uncorrected distance VA improved in 2 of 3 patients^Citation25	Posterior capsule opacification (1 eye)^Citation25
Lentis Max	Monocular, 1.5x at 30cm; 3x at 15cm^Citation26	Case series, binocular BCDVA increased to 0.5 (logMAR)^Citation26	“The postoperative course was uneventful”^Citation26

Grzybowski A, Wasinska-Borowiec W, ALio J, Amat-Peral P, Tabanero J. Intraocular lenses in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255:1687–1696. doi:10.1007/s00417-017-3740-8

 Web of Science ®Google Scholar

Dunbar H, Dhawahir-Scala F. A discussion of commercially available itra-ocular telescopic implants for patients with age-related macular degeneration. Ophthalmol Ther. 2018;7:33–48. doi:10.1007/s40123-018-0129-7

 Web of Science ®Google Scholar

Boyer D, Bailey Freund K, Regillo C, Levy M, Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–1107. doi:10.2147/OPTH.S86208

 PubMedGoogle Scholar

ALio J, Mulet E, Ruiz-Moreno J, Jose Sanchez M, Galal A. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–1189. doi:10.1016/j.jcrs.2003.10.038

 Web of Science ®Google Scholar

Orzalesi N, Pierrottet C, Zenoni S, Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmol. 2007;114:860–865. doi:10.1016/j.ophtha.2007.01.005

 PubMed Web of Science ®Google Scholar

Qureshi M, Robbie S, Hengerer F, Auffarth G, Conrad-Hengerer I, Artal P. Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol. 2018;28:198–203. doi:10.5301/ejo.5001052

 Web of Science ®Google Scholar

Nekolova J, Rozsival P, Sin M, Jiraskova N. Scharioth Macula Lens: a new intraocular implant for low-vision patients with stabilized maculopathy - first experience. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161:206–209. doi:10.5507/bp.2017.014

 Web of Science ®Google Scholar

Srinivasan S, Scharioth G, Riehl A, et al. Implantation of Scharioth macula lens in patients with age-related macular degenration: results of a propsective European multicentre clinical trial. BMJ Open Ophthalmol. 2019;4:e000322. doi:10.1136/bmjophth-2019-000322

 Web of Science ®Google Scholar

Borkenstein A, Borkenstein EM. A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders. Medicine. 2019;98:e16583. doi:10.1097/MD.0000000000016583

 Web of Science ®Google Scholar

Potgeiter F, Claoue C. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014;40:1085–1091. doi:10.1016/j.jcrs.2013.10.049

 Web of Science ®Google Scholar

Borkenstein A, Borkenstein EM. Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: a case report of magnifying surgery. Clin Case Rep. 2018;7:74–78. doi:10.1002/ccr3.1912

 Web of Science ®Google Scholar